Notice of Clarification of Award Budget and Eligible Foreign Institutions for PAR-13-007 Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01)

Notice Number: NOT-DK-13-016

Key Dates
Release Date: August 7, 2013

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice is to clarify the Award Budget and Eligibility of Foreign Institutions for PAR-13-007 "Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01)."

The following sections of PAR-13-007 are modified accordingly.

Section II. Award Information

Current language:

Award Budget

Applications are limited to $500,000 in direct costs per year and the budget must reflect the scope of the proposed project.

Modified language:

Award Budget

Applications are limited to less than $500,000 in direct costs per year and the budget must reflect the scope of the proposed project.


Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Current language:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Modified language:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Dr. Aaron Pawlyk
Division of Diabetes, Endocrinology, and Metabolic Diseases
National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-7299
Email: pawlykac@mail.nih.gov